GlassScriptPhysician profile
Roslyn Chosak
NPI 1528023181
$2,782.17
in general payments reported to CMS, 2019-2025
22 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $745 · 2021: $384 · 2022: $58.80 · 2023: $455 · 2024: $221 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.51 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $870.06 | 2019-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $500.70 | 2019-2024 | |
| Abbvie INC. | $180.67 | 2020-2023 | Lo Loestrin Fe |
| Bard Peripheral Vascular, INC. | $140.24 | 2020 | |
| Exact Sciences Corporation | $137.33 | 2023-2024 | Cologuard Collection Kit |
| Millicent US INC | $127.27 | 2019-2025 | Intrarosa, Femring |
| Sumitomo Pharma America, INC. | $122.24 | 2024-2025 | Gemtesa |
| Therapeuticsmd, INC. | $110.26 | 2020-2021 | |
| Boston Scientific Corporation | $101.56 | 2019 | |
| Amgen INC. | $80.17 | 2019 | |
| Philips North America LLC | $75.10 | 2020 | |
| Inari Medical, INC. | $68.45 | 2020 | |
| Duchesnay USA Incorporated | $48.19 | 2019 | |
| Allergan, INC. | $37.15 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $33.70 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $33.06 | 2019-2020 | |
| Avion Pharmaceuticals | $23.52 | 2019 | |
| Roche Diagnostics Corporation | $22.75 | 2019 | |
| Lupin INC. | $21.58 | 2019 | |
| Amag Pharmaceuticals, INC. | $20.58 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.96 | 2019 | |
| Mayne Pharma Commercial LLC | $8.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roslyn Chosak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.